FI115054B - Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi Download PDF

Info

Publication number
FI115054B
FI115054B FI910925A FI910925A FI115054B FI 115054 B FI115054 B FI 115054B FI 910925 A FI910925 A FI 910925A FI 910925 A FI910925 A FI 910925A FI 115054 B FI115054 B FI 115054B
Authority
FI
Finland
Prior art keywords
methyl
oxo
oxetanyl
group
alkyl
Prior art date
Application number
FI910925A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI910925A0 (fi
FI910925A (fi
Inventor
Hans Peter Maerki
Andre Szente
Henri Stalder
Romano Derungs
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI910925A0 publication Critical patent/FI910925A0/fi
Publication of FI910925A publication Critical patent/FI910925A/fi
Application granted granted Critical
Publication of FI115054B publication Critical patent/FI115054B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
FI910925A 1990-02-26 1991-02-26 Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi FI115054B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH60490 1990-02-26
CH60490 1990-02-26
CH400590 1990-12-17
CH400590 1990-12-17

Publications (3)

Publication Number Publication Date
FI910925A0 FI910925A0 (fi) 1991-02-26
FI910925A FI910925A (fi) 1991-08-27
FI115054B true FI115054B (fi) 2005-02-28

Family

ID=25685091

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910925A FI115054B (fi) 1990-02-26 1991-02-26 Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0444482B1 (es)
JP (1) JP2753403B2 (es)
KR (1) KR0183036B1 (es)
AT (1) ATE133167T1 (es)
AU (1) AU645291B2 (es)
CA (1) CA2035967C (es)
DE (1) DE59107262D1 (es)
DK (1) DK0444482T3 (es)
ES (1) ES2082869T3 (es)
FI (1) FI115054B (es)
GR (1) GR3019618T3 (es)
HU (1) HU218272B (es)
IE (1) IE72196B1 (es)
IL (1) IL97148A (es)
MC (1) MC2226A1 (es)
NO (1) NO177055C (es)
NZ (1) NZ237170A (es)
PT (1) PT96887B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
NL1004559C2 (nl) * 1996-11-18 1998-05-19 Unilife Boter.
AU1238101A (en) * 1999-10-29 2001-05-14 John Jason Gentry Mullins Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
DE102004009076A1 (de) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
CA2704462A1 (en) 2007-10-31 2009-05-07 Burnham Institute For Medical Research Beta-lactone compounds
AU2018300985A1 (en) * 2017-07-12 2020-01-30 Mayo Foundation For Medical Education And Research Compounds for the reducing lipotoxic damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (ja) * 1984-08-09 1994-08-31 三菱電機株式会社 遅延線

Also Published As

Publication number Publication date
NO910729D0 (no) 1991-02-25
EP0444482B1 (de) 1996-01-17
ES2082869T3 (es) 1996-04-01
CA2035967C (en) 2001-10-16
MC2226A1 (fr) 1993-02-02
FI910925A0 (fi) 1991-02-26
DK0444482T3 (da) 1996-05-06
KR0183036B1 (ko) 1999-05-01
PT96887A (pt) 1991-10-31
FI910925A (fi) 1991-08-27
HU218272B (en) 2000-07-28
AU645291B2 (en) 1994-01-13
IL97148A0 (en) 1992-05-25
CA2035967A1 (en) 1991-08-27
JP2753403B2 (ja) 1998-05-20
IE72196B1 (en) 1997-03-26
ATE133167T1 (de) 1996-02-15
AU7122891A (en) 1991-08-29
JPH0770099A (ja) 1995-03-14
GR3019618T3 (en) 1996-07-31
PT96887B (pt) 1998-09-30
DE59107262D1 (de) 1996-02-29
NO910729L (no) 1991-08-27
NO177055B (no) 1995-04-03
NZ237170A (en) 1993-12-23
KR910021391A (ko) 1991-12-20
IL97148A (en) 1996-11-14
EP0444482A2 (de) 1991-09-04
NO177055C (no) 1995-07-12
IE910631A1 (en) 1991-08-28
EP0444482A3 (en) 1991-12-04
HUT56557A (en) 1991-09-30

Similar Documents

Publication Publication Date Title
US5466708A (en) Oxetanones
JP3569550B2 (ja) 縮合二環式環含有化合物およびその製造法
RU2135515C1 (ru) Карбаматы и карбамиды, индуцирующие производство цитокинов
DE69309047T2 (de) Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren
FI115054B (fi) Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi
HUT74511A (en) Metalloproteinase inhibitors, pharmaceutical compns. contg. them and process to prepare the said compds.
DE2925945C2 (es)
AU3895900A (en) Novel compounds and compositions as protease inhibitors
CA1101846A (en) Derivatives of 4-hydroxy-phenylglycine
US5109000A (en) Thiol carboxylic acid derivatives and their use as collagenase inhibitor
WO2007144169A2 (en) Entacapone-derivatives
JP4428053B2 (ja) ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物
HUT57705A (en) Process for producing acat-inhibitors
FR2500832A1 (fr) Composes de derives de bis (carboxamide) et composition pharmaceutique comprenant ces composes
US6110933A (en) Amino acid derivatives and their use as phospholipase A2 inhibitor
EP0520427B1 (en) Cyclopropenone derivatives
CZ281839B6 (cs) Derivát aminokyseliny, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
CZ298048B6 (cs) Farmaceutický prostredek a deriváty kyseliny hydroxamové
US7777071B2 (en) Production of carnitine conjugate intermediates
JP3361836B2 (ja) アミノ酸誘導体
JP6849615B2 (ja) チアジドアミド誘導体とその利用
EP0925786A1 (en) Remedies for ischemic diseases
CA2049390A1 (en) Novel peptide derivatives and their pharmaceutical use
JPH0788334B2 (ja) Ｎ−メチルフエニルセリン誘導体
KR20010020452A (ko) 금속 단백질 분해효소 억제제

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115054

Country of ref document: FI

MA Patent expired